参考文献/References:
[1] 周桃桃,郭兆安.DKD发病机制研究进展[J].现代中西医结合杂志,2021,30(34):3872-3876.
[2] 谢席胜,艾 娜,王宝福,等.DKD流行病学研究进展[J].中国中西医结合肾病杂志,2013,14(10):937-940.
[3] 顾红岩,冯兴中.中医药辨证治疗早期DKD概况[J].四川中医,2017,35(6):212-214.
[4] 陈茂盛,金 娟,刘岳明,等.基于病理学分期的DKD中医辨证分型研究[J].中华中医药学刊,2016,34(11):2668-2672.
[5] 边丽云,蔡国艳.DKD的中医治疗经验[J].糖尿病新世界,2015,18(14):192-193,198.
[6] 李秀华,李凤婷,李 梦,等.DKD中医病名及病因病机浅述[J].安徽中医学院学报,2010,29(6):7-9.
[7] Galluzzi L,Green DR.Autophagy-independent functions of the autophagy machinery[J].Cell,2019,177(7):1682-1699.
[8] Tang C,Livingston MJ,Liu Z,et al.Autophagy in kidney homeostasis and disease[J].Nat Rev Nephrol,2020,16(9):489-508.
[9] Chang J,Zhou Y,Cong G,et al.Dendrobium candidum protects against diabetic kidney lesions through regulating vascular endothelial growth factor,glucose transporter 1,and connective tissue growth factor expression in rats[J].J Cell Biochem,2019,120(8):13924-13931.
[10] 李 波,金伶佳,吴美兰.雷公藤临床应用、毒性及减毒增效研究进展[J].中华中医药杂志,2020,35(7):3539-3541.
[11] 李晶芳,韩 蕊,殷宏庆,等.雷公藤治疗肾脏疾病及其不良反应的研究进展[J].中国实验方剂学杂志,2021,27(14):229-234.
[12] 李 乔,张 博.雷公藤甲素通过抑制TLR4基因对DKD足细胞的保护作用[J].临床与病理杂志,2020,40(4):831-836.
[13] 王亚娟.雷公藤乙素对DKD大鼠肾脏中转化生长因子β1的影响[J].浙江中医杂志,2013,48(4):270-272.
[14] 涂亚芳.树突状细胞在实验性糖尿病肾损害中作用及迁徙机制的研究[D].武汉:武汉大学,2011.
[15] 吕楚风,方 成.糖尿病及DKD的自身免疫[J].中国糖尿病杂志,2017,25(3):281-284.
[16] Dagar N,Das P,Bisht P,et al.Diabetic nephropathy:A twisted thread to unravel[J].Life Sci,2021,278:119635.
[17] Chiumello G,Beccaria L,Meschi F,et al.Etiology,diagnosis,and prevention of renal involvement in insulin-dependent diabetes mellitus[J].Pediatrician,1983,12(4):199-207.
[18] Wei TT,Yang LT,Guo F,et al.Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy[J].Acta Pharmacol Sin,2021,42(2):252-263.
[19] Cui J,Bai X,Chen X.Autophagy and diabetic nephropathy[J].Adv Exp Med Biol,2020,1207:487-494.
[20] 林 绥,邓思珊,阙慧卿,等.雷公藤中雷公藤甲素和雷公藤乙素的测定[J].中草药,2008,39(9):1409-1411.
[21] 吴 冰,王 轩.基于Notch信号通路探讨枸杞多糖对糖尿病肾病大鼠肾纤维化的改善作用[J].陕西医学杂志,2023,52(3):267-272.
[22] Dikic I,Elazar Z.Mechanism and medical implications of mammalian autophagy[J].Nat Rev Mol Cell Biol,2018,19(6):349-364.
[23] Xu J,Deng Y,Wang Y,et al.SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway[J].Cell Prolif,2020,53(2):e12738.
[24] Moutzouris DA,Kitsiou PV,Talamagas AA,et al.Chronic exposure of human glomerular epithelial cells to high glucose concentration results in modulation of high-affinity glucose transporters expression[J].Ren Fail,2007,29(3):353-358.
[25] Rufino M,Hernandez D,Barrios Y,et al.The GLUT-1 XbaI gene polymorphism is associated with vascular calcifications in nondiabetic uremic patients[J].Nephron Clin Pract,2008,108(3):182-187.
[26] 朱宜临,钱秋海,张新颖.DKD中西医研究进展[J].山东中医杂志,2017,36(1):82-84,88.
[27] 刘玉栋,孟祥云,程 涛,等.DKD中西医发病机制及治疗概述[J].西部中医药,2019,32(7):134-138.
[28] 刘 晶,沈宝华,冉颖卓.益肾固摄活血通络法治疗肾虚血瘀型糖尿病肾病临床疗效[J].陕西中医,2023,44(4):446-450.
[29] 魏华娟,赵然然,李世媛,等.通络解毒汤对糖尿病肾病大鼠抗氧化通路的作用机制[J].陕西中医,2022,43(12):1669-1672.
[30] 刘 芳,张立祥,王慧敏,等.养生益肾汤对糖尿病肾病患者血清细胞因子水平及肾功能的影响[J].陕西中医,2022,43(4):476-478,486.
[31] 马瑞霞,赵 娜,张 伟.雷公藤多甙联合厄贝沙坦对糖尿病肾病患者尿足细胞排泄影响及机制探讨[J].中华内科杂志,2013,52(6):469-473.
[32] Sun X,Shen B,Yu H,et al.Therapeutic potential of demethylzeylasteral,a triterpenoid of the genus tripterygium wilfordii[J].Fitoterapia,2022,163:105333.
[33] Jin D,Yu M,Li X,et al.Efficacy of tripterygium wilfordii hook F on animal model of diabetic kidney diseases:A systematic review and meta-analysis[J].J Ethnopharmacol,2021,281:114536.
[34] Luo D,Zuo Z,Zhao H,et al.Immunoregulatory effects of tripterygium wilfordii hook F and its extracts in clinical practice[J].Front Med,2019,13(5):556-563.
[35] 艾丽曼,王 顺.雷公藤多苷联合小剂量激素治疗特发性膜性肾病疗效研究[J].陕西中医,2022,43(6):712-714.
[36] 任凌燕,朱 鸣,朱华艳,等.雷公藤甲素通过调控Toll-样受体(TLR)/核因子κB(NF-κB)信号通路对糖尿病肾病模型小鼠足细胞的作用研究[J].浙江中西医结合杂志,2020,30(3):191-195,263.
[37] 杨 朔,胡俊华,王亚娟,等.雷公藤乙素对糖尿病肾病大鼠肾组织p-p38MAPK TNF-α及IL-1β表达的影响[J].中国中医药科技,2021,28(6):897-900.
相似文献/References:
[1]张华贞.复方黄芪汤加减联合骨化三醇治疗糖尿病肾病疗效及对患者血糖、肾功的影响*[J].陕西中医,2019,(6):767.
[2]程红卫,成晓萍.阎晓萍从脾论治糖尿病肾病经验总结*[J].陕西中医,2019,(6):790.
[3]黄聪丽,王治新△.益气滋肾活血通络方治疗早中期糖尿病肾病临床研究[J].陕西中医,2019,(10):1390.
HUANG Congli,WANG Zhixin..Clinical efficacy analysis of Yiqi Zishen Huoxue Tongluo decoctionon early and medium stage of diabetic nephropathy[J].,2019,(8):1390.
[4]玉山江·艾克木,哈丽达·木沙△,地丽尼嘎尔.西红康联合还原型谷胱甘肽治疗2型糖尿病肾病Ⅲ期气阴两虚夹瘀证疗效及对患者微炎症状态、抗氧化的影响*[J].陕西中医,2020,(3):338.
Yushanjiang·Aikemu,Halida·Musha,Dilinigaer..Efficacy of adjuvant therapy of Xihongkang on type 2 diabetic nephropathy Ⅲ phase with syndrome of Qiyin Liangxu Jiayu type and its effect on micro inflammation and antioxidant role[J].,2020,(8):338.
[5]马民凯,马红建,陈新苗.通络散结汤对3期糖尿病肾病患者GFR、UAER、β2-MG、Cys-C及微炎症状态的影响*[J].陕西中医,2020,(10):1432.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.025]
[6]田娟娟,陈 强,周欣欣,等.益气养阴活血法治疗糖尿病肾病理论探究*[J].陕西中医,2020,(12):1781.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.026]
[7]代广玉,修丽梅.糖尿病肾病中医辨证分型研究进展[J].陕西中医,2021,(1):131.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.036]
[8]赵 亚,张勉之,樊威伟,等.国医大师张大宁治疗糖尿病肾病用药经验[J].陕西中医,2021,(6):773.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.025]
[9]张 蕊,王子承,蒋荣莉,等.防己黄芪汤加味治疗糖尿病肾病疗效及对患者糖脂代谢、氧化应激的影响[J].陕西中医,2021,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
ZHANG Rui,WANG Zicheng,JIANG Rongli,et al.Effect of Fangji Huangqi decoction on diabetic nephropathy and its influence on glucose and lipid metabolism and oxidative stress[J].,2021,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
[10]方锦颖,王一冲,神原优滋(日本),等.基于网络药理学和分子对接探究肾康注射液治疗糖尿病肾病作用机制[J].陕西中医,2021,(12):1798.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.039]